Promaxo Inc. of Oakland, Calif., sold eight of its systems for performing AI-equipped, MRI-guided prostate interventions in the fourth quarter of 2022. The company launched a year prior and has now topped $15 million in sales.  

The heads of RBMA and three other medical management associations are locking arms and pointing their voices in the general direction of Washington.

Less than a week after ringing the Nasdaq opening bell to showcase its long-awaited independence, GE HealthCare has announced a first strategic acquisition is in the works.

The independent-practice coalition Strategic Radiology has founded a captive health insurance program to offer its 1,500 or so member physicians and their respective support staffs.  

A med-tech leader of note is taking skills refined at Amazon, the FDA and the CDC to GE HealthCare, where he will serve as the newly independent company’s first CTO. 

GE HealthCare has begun trading as an independent company on the Nasdaq exchange. To mark the occasion and showcase its completed spinoff from General Electric, the company remotely rang the opening bell at Nasdaq from its manufacturing facility in Waukesha, Wis.

A published list shows all three grossing an annual salary of at least $1.95 million in Canadian Medicare billings.

The FDA has cleared Polarean Imaging’s xenon gas-based MRI contrast agent for evaluating pulmonary function in patients aged 12 years and up.